Moda Health does cover Wegovy on most commercial and Health Exchange plans, but almost always with prior authorization and quantity limits attached. Employer group plans administered by Moda may cover it with fewer restrictions, while Oregon’s public employee plans and standard Medicare Part D generally do not list Wegovy as a covered weight-loss drug. The fastest way to confirm what your specific plan does is to log into myModa and run the prescription price check tool, or call Moda Pharmacy Customer Service.
How Coverage Breaks Down by Plan
Wegovy appears on Moda’s formulary across seven plan categories for 2026, with different rules attached to each.1PrescriberPoint. Wegovy Coverage – Moda Health
- Commercial PPO and HMO plans cover Wegovy, but require prior authorization and apply quantity limits.
- Commercial employer group plans cover Wegovy with no prior authorization, no step therapy, and no quantity limits.
- Health Exchange plans — PPO, HDHP, and POS — all require prior authorization and apply quantity limits.
- The Medicare Prescription Drug Plan formulary lists Wegovy with no prior authorization, no step therapy, and no quantity limits, though separate federal rules control what Medicare will actually pay for.
Step therapy does not apply to Wegovy on any of these plans, so you are not required to try a different weight-loss medication first.1PrescriberPoint. Wegovy Coverage – Moda Health
What Prior Authorization Actually Requires
For most Moda commercial and exchange plans, your doctor has to submit a prior authorization request before the pharmacy will fill Wegovy at the insured rate. The diagnosis on the prescription matters. In a January 2023 provider update, Moda announced that GLP-1 claims for commercial and exchange members must carry a diagnosis code matching the drug’s FDA-approved indication, and that “exclusions under a member’s plan benefit design, such as treatment for weight loss, still apply.”2Moda Health. Moda Medical Office Update – January 2023 Wegovy carries its own FDA approval for chronic weight management and cardiovascular risk reduction, so it is not the off-label case that notice was aimed at, but the underlying rule still shapes how Moda reviews these claims: the indication on the prescription has to line up with what the plan covers.
What Wegovy Will Cost You
Moda uses a tiered formulary with Value, Select, Preferred, and Non-Preferred tiers, and your copay or coinsurance depends on both the tier Wegovy sits in and your specific plan design.3Moda Health. Preferred Drug List There is no single published price. To get your number:
- Log into myModa at modahealth.com, open the Pharmacy tab, and use the prescription price check tool.
- Call Moda Pharmacy Customer Service at 888-361-1610 for commercial plans, or 844-235-8017 for plans on the Navitus pharmacy network.4Moda Health. Formularies
Oregon Public Employee Plans (OEBB and PEBB)
If your Moda coverage comes through the Oregon Educators Benefit Board or the Public Employees Benefit Board, the picture is different. The OEBB plan handbook does not list Wegovy or other GLP-1 weight-loss drugs as covered benefits. OEBB offers a weight management program as a “value-added service,” but the handbook states those services are “not part of the Plan” and “are not insurance.”5Moda Health. 2025 OEBB Medical Handbook – Plan 6 OEBB members can confirm specific drug coverage through the Member Dashboard or by calling Pharmacy Customer Service at 866-923-0411.6Moda Health. OEBB Members – Pharmacy
The PEBB High Performance Formulary, last updated June 2026, does not list any GLP-1 agonists in its anti-obesity drug category; that section covers only ADHD stimulants and related medications.7Moda Health. PEBB High Performance Formulary PEBB members can verify coverage at 844-776-1594 or through myModa.8Moda Health. PEBB Members – Pharmacy
Medicare Members and the GLP-1 Bridge
Medicare has historically been barred by law from covering medications used solely for weight loss. Moda’s Medicare Prescription Drug Plan formulary lists Wegovy without prior authorization, but the 2026 formulary documents do not include Wegovy as a covered drug in the anti-obesity category.9Moda Health. 2026 Moda Health Rx Formulary Part D coverage is generally limited to FDA-approved indications beyond weight loss, such as cardiovascular risk reduction.
A federal demonstration changed the picture temporarily. The Medicare GLP-1 Bridge program took effect July 1, 2026, and runs through December 31, 2026. It covers Wegovy (injection and tablets), Zepbound, and Foundayo for weight loss outside the standard Part D benefit, so Moda’s Part D plan is not directly processing these claims.10CMS. Medicare GLP-1 Bridge Eligible beneficiaries pay a $50 monthly copay per supply, which does not count toward Part D deductibles or out-of-pocket limits. A BMI of 35 or higher qualifies you automatically; a lower BMI requires at least one qualifying condition such as prediabetes, uncontrolled hypertension, chronic kidney disease, or a prior heart attack or stroke.11Medicare.gov. Weight Loss Drugs Beneficiaries already receiving a GLP-1 through Part D for a condition like type 2 diabetes are not eligible for the Bridge.
A longer-term successor, the BALANCE Model, is scheduled to begin January 1, 2027, but only if at least 80% of Part D plan sponsors opt in. Participation is voluntary, so if your plan does not join, Wegovy coverage for weight loss would end when the Bridge expires.12KFF. What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
Oregon Health Plan (Medicaid) Limits
Moda administers coverage for some Oregon Health Plan members, and OHP rules are tighter than its commercial rules. OHP does not cover weight-management drugs for adults who do not have established cardiovascular disease or type 2 diabetes.13Oregon PDUR/DHS. Semaglutide Prior Authorization Update
OHP may cover Wegovy specifically for preventing a second cardiovascular event when a patient meets all of the following: age 45 or older, BMI of 27 or greater, established cardiovascular disease (such as prior heart attack, stroke, or symptomatic peripheral arterial disease), a negative diabetes screening within the past 12 months, and a documented weight-loss treatment plan attempted for at least three months within the previous six months.14CareOregon. GLP-1 for Non-Diabetes Indications PA Criteria Initial authorization runs up to six months; renewals of up to 12 months depend on adherence and demonstrated weight reduction.
If Moda Denies Your Prior Authorization
You and your prescriber have options before filing a formal appeal. Your doctor can request a peer-to-peer review by calling 800-258-2037 to speak with a Moda medical director, or fax additional medical records to 503-243-5105 for a fresh review.15Moda Health. Prior Authorization Denial
A formal appeal must be in writing and submitted within 180 days of the denial letter. Include your name, date of birth, Moda ID number, and dates of service. You can use Moda’s Complaint and Appeal Form from modahealth.com or write a letter. Mail appeals to Moda Health, Attention: Appeal Unit, P.O. Box 40384, Portland, OR 97240-0384, or fax to 503-412-4003.15Moda Health. Prior Authorization Denial
Moda notes that denials often happen because more information is needed. A stronger appeal typically includes a detailed health history, relevant test results, documentation that other approaches were tried or considered, and evidence of obesity-related conditions such as heart disease, diabetes, hypertension, or sleep apnea that support medical necessity.